Broadhi Capital
VC Fund
Shanghai, China
Broadhi Capital is a venture capital and private equity firm specializing in growth and mature stage investments. For mature companies, the firm seeks to invest in firms that are in Pre-IPO stage and can be listed in an IPO within 2-3 years. For growth companies, it seeks to invest in firms that can be listed in an IPO within 1-3 years. The firmprefers to invest in biomedical, biotechnology, new consumer, energy conservation, clean technology, new materials, advanced manufacturing, medical treatment, environment protection, electronic information technology, energy saving, equipment, consumer, new materials, and modern agriculture industry. It typically invests in companies based in China, especially in Henan Province. The firm seeks to have a minority stake of 35% or lower in their portfolio companies. Broadhi Capital was founded on July 2008 and is based in Shanghai, China with additional offices in Beijing, China and Zhengzhou, China.
- Total investments:
- 16
- Last investment:
- Lead investor:
- 13%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Broadhi Capital invests in
Stages Broadhi Capital invests in
Countries Broadhi Capital invests in
Round sizes
Round size
- Angel
- $68k–$752k
- Series A
- $221k–$43M
Investment Focus
Industry
- Health Care 7 (44%)
- Medical 6 (38%)
- Mobile 4 (25%)
- Manufacturing 4 (25%)
- Agriculture 2 (13%)
Stage
- Angel 5 (31%)
- Series A 5 (31%)
- Series B 2 (13%)
- Seed 1 (6%)
- Series C 1 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Abiochem Biotechnology
|
Abiochem Biotechnology is a high-tech enterprise with leading enzyme engineering technology and genetic engineering technology. Engaged in the research and development of biocatalytic and synthetic biology methods, and is committed to its application to large-scale production. It is widely used in the fields of medicine, health care products,pesticides, etc., and has contributed to the promotion and development of green chemistry. | Series A / Nov 28, 2020 | |
|
Abiochem Biotechnology
|
Abiochem Biotechnology is a high-tech enterprise with leading enzyme engineering technology and genetic engineering technology. Engaged in the research and development of biocatalytic and synthetic biology methods, and is committed to its application to large-scale production. It is widely used in the fields of medicine, health care products,pesticides, etc., and has contributed to the promotion and development of green chemistry. | Series A / Apr 03, 2019 | |
Thousand Oaks Biopharmaceuticals
|
Thousand Oaks Biopharmaceuticals is a developer of biopharmaceutical technologies intended to produce protein and vaccine compounds. The company's technologies provide integrated control solutions, including the use of technical expertise to optimize the process and increase protein expression to reduce production scale, providingbio-pharmaceutical companies with personalized, chemical-defined cell culture media, formula production, technical support and ancillary services. | $42.5M / Series A / Jan 01, 2019 | |
Jin Yu Medical
|
Jinyu Medical focuses on remote clinics and family doctor services. | Seed / Oct 24, 2018 | |
Sinagri YingTai
|
Sinagri YingTai is a producer of green alternative products that conducts research and development in the fields of animal nutrition, biological veterinary medicine, biological medicine, health care products, cosmetics, and other fields. Their products include animal health, veterinary medicine, and raw materials. | Series B / Jul 23, 2018 | |
Fansheng Tuxiang
|
Fansheng Tuxiang company has a number of wholly-owned subsidiaries as well as R&D centers, laboratories, and offices. They offer a modular design and a tool-based application platform to quickly and affordably implement the laboratory standard in the mass production process. | $421K / Series B / Jul 20, 2016 | |
TM' Holter
|
TM' Holter is an application development of intelligent biosensing systems. | $221K / Series A / Oct 22, 2015 | |
Panther Healthcare
|
Panther Healthcare develops and manufactures surgical stapling and minimally invasive endo surgery products. | $15.2M / Series A / Jun 19, 2015 | |
Cooee Technology
|
Cooee Technology is a mobile game developer company. | $425K / Angel / May 29, 2015 | |
Uliaobao.com
|
uliaobao provides online sales of fabric products. They provide cotton, woolen blended fabrics, chemical fabrics, and others. They allow consumers to directly buy goods or services from a seller over the internet using a web browser or a mobile app. Their products serve consumers. | $752K / Angel / May 29, 2015 | |
| See all 16 investments → | |||
Co-Investors
Beiruan Angle
2 deals together
Huatai Zijin Investment
2 deals together
Addor Capital
1 deal together
Haitong-Fortis Private Equity Fund Management
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Broadhi Capital invest in?
Broadhi Capital invests primarily in Health Care, Medical and Mobile startups, most often at Angel and Series A stage. Most of the 16 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Broadhi Capital's check size?
Broadhi Capital typically joins rounds of $68k–$752k at Angel and $221k–$43M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Broadhi Capital participates in.
When did Broadhi Capital last invest?
The most recent investment recorded for Broadhi Capital closed in Nov 2020. Shizune tracks 16 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
